NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 448 filers reported holding NOVAVAX INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $952,386 | +658.4% | 75,228 | +315.2% | 0.00% | – |
Q1 2023 | $125,572 | -34.5% | 18,120 | -2.8% | 0.00% | – |
Q4 2022 | $191,568 | -42.3% | 18,635 | +2.2% | 0.00% | – |
Q3 2022 | $332,000 | -64.9% | 18,240 | -0.9% | 0.00% | – |
Q2 2022 | $947,000 | +46.1% | 18,406 | +109.2% | 0.00% | – |
Q1 2022 | $648,000 | -33.9% | 8,800 | +85.9% | 0.00% | – |
Q3 2021 | $981,000 | -50.5% | 4,734 | -49.3% | 0.00% | -100.0% |
Q2 2021 | $1,983,000 | -37.2% | 9,341 | -46.4% | 0.00% | 0.0% |
Q1 2021 | $3,160,000 | +45.1% | 17,428 | -10.8% | 0.00% | 0.0% |
Q4 2020 | $2,178,000 | +1.9% | 19,534 | -1.0% | 0.00% | 0.0% |
Q3 2020 | $2,138,000 | – | 19,732 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 3,002,087 | $544,308,000 | 8.21% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 323,517 | $58,657,000 | 7.86% |
Samsara BioCapital, LLC | 198,600 | $36,008,000 | 6.64% |
Foresite Capital Management I, LLC | 66,810 | $12,113,000 | 6.11% |
Foresite Capital Management II, LLC | 67,373 | $12,215,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 191,200 | $34,666,000 | 2.63% |
Rock Springs Capital Management LP | 461,000 | $83,584,000 | 1.82% |
TSP Capital Management Group, LLC | 23,525 | $4,265,000 | 1.50% |
Ikarian Capital, LLC | 195,700 | $35,483,000 | 1.19% |
SevenOneSeven Capital Management | 1,744 | $316,000 | 1.16% |